98-10023. Spinosad; Pesticide Tolerances  

  • [Federal Register Volume 63, Number 72 (Wednesday, April 15, 1998)]
    [Rules and Regulations]
    [Pages 18329-18338]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-10023]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    
    40 CFR Part 180
    
    [OPP-300644; FRL-5785-7]
    RIN 2070-AB78
    
    
    Spinosad; Pesticide Tolerances
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This regulation establishes permanent tolerances for residues 
    of spinosad in or on almonds at 0.02 parts per million (ppm); almond 
    hulls at 2.0 ppm; apples at 0.2 ppm; apple pomace, wet at 0.5 ppm; 
    citrus fruits group at 0.3 ppm; citrus pulp, dried at 0.5 ppm; citrus 
    oil at 3.0 ppm; cottonseed at 0.02 ppm; cotton gin byproducts at 1.5 
    ppm; fruiting vegetables (except cucurbits) group at 0.4 ppm; Brassica 
    (cole), leafy vegetables, head and stem subgroup at 2.0 ppm; Brassica 
    (cole), leafy vegetables, greens subgroup at 10.0 ppm; leafy vegetables 
    (except Brassica vegetables) group at 8.0 ppm; fat of cattle, goats, 
    hogs, horses, and sheep at 0.6 ppm; meat of cattle, goats, hogs, 
    horses, and sheep at 0.04; meat byproducts of cattle, goats, hogs, 
    horses, and sheep at 0.2 ppm; milk fat at 0.5 ppm; and whole milk at 
    0.04 ppm. This regulation also removes the time limitation for the 
    tolerance for residues of spinosad on cottonseed which expires on 
    November 15, 1999. DowElanco requested these tolerances under the 
    Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food 
    Quality Protection Act of 1996 (FQPA) (Pub. L. 104-170). In addition, 
    this regulation removes time-limited tolerances set under section 
    408(1)(6) of the FFDCA, as amended by the FQPA for residues of spinosad 
    on fruiting vegetables (except cucurbits) group, tomato paste, leafy 
    vegetables (except Brassica vegetables) group, and Brassica (cole), 
    leafy vegetables, group at 0.25, 0.50, 10.0, and 10.0 ppm, 
    respectively. These tolerances were set under the
    
    [[Page 18330]]
    
    section 18 emergency exemption provision of the FQPA and they expire on 
    September 30, 1998. With this regulation, permanent tolerances are now 
    being established to replace these time-limited tolerances with the 
    exception of tomato paste. A tolerance will not be established for 
    tomato paste because EPA has determined that the maximum amount of 
    spinosad residues expected in tomato paste is less than the proposed 
    tolerance for tomatoes. Therefore, no tolerance is required for tomato 
    paste.
    
    
    DATES: This regulation is effective April 15, 1998. Objections and 
    requests for hearings must be received by EPA on or before June 15, 
    1998.
    
    
    ADDRESSES: Written objections and hearing requests, identified by the 
    docket control number, [OPP-300644], must be submitted to: Hearing 
    Clerk (1900), Environmental Protection Agency, Rm. M3708, 401 M St., 
    SW., Washington, DC 20460. Fees accompanying objections and hearing 
    requests shall be labeled ``Tolerance Petition Fees'' and forwarded to: 
    EPA Headquarters Accounting Operations Branch, OPP (Tolerance Fees), 
    P.O. Box 360277M, Pittsburgh, PA 15251. A copy of any objections and 
    hearing requests filed with the Hearing Clerk identified by the docket 
    control number, [OPP-300644], must also be submitted to: Public 
    Information and Records Integrity Branch, Information Resources and 
    Services Division (7502C), Office of Pesticide Programs, Environmental 
    Protection Agency, 401 M St., SW., Washington, DC 20460. In person, 
    bring a copy of objections and hearing requests to Rm. 119, CM #2, 1921 
    Jefferson Davis Hwy., Arlington, VA.
        A copy of objections and hearing requests filed with the Hearing 
    Clerk may also be submitted electronically by sending electronic mail 
    (e-mail) to: opp-docket@epamail.epa.gov. Copies of objections and 
    hearing requests must be submitted as an ASCII file avoiding the use of 
    special characters and any form of encryption. Copies of objections and 
    hearing requests will also be accepted on disks in WordPerfect 5.1/6.1 
    file format or ASCII file format. All copies of objections and hearing 
    requests in electronic form must be identified by the docket control 
    number [OPP-300644]. No Confidential Business Information (CBI) should 
    be submitted through e-mail. Electronic copies of objections and 
    hearing requests on this rule may be filed online at many Federal 
    Depository Libraries.
    
    FOR FURTHER INFORMATION CONTACT: By mail: Beth Edwards, Registration 
    Division 7505C, Office of Pesticide Programs, Environmental Protection 
    Agency, 401 M St., SW., Washington, DC 20460. Office location, 
    telephone number, and e-mail address: Crystal Mall #2, 1921 Jefferson 
    Davis Hwy., Arlington, VA, (703) 305-5400, e-mail: 
    edwards.beth@epamail.epa.gov.
    
    
    SUPPLEMENTARY INFORMATION: On February 26, 1997, EPA established a 
    time-limited tolerance under section 408 and 409 of the FFDCA, 21 
    U.S.C. 346a(d) and 348 for residues of spinosad on cottonseed (62 FR 
    8626) (FRL-5590-8). This tolerance expires on November 15, 1999. 
    DowElanco, on December 11, 1997, requested that the time limitation be 
    removed based on a cotton gin trash residue study that they had 
    submitted as a condition of the registration and the time-limited 
    tolerance. DowElanco also submitted a summary of its petition as 
    required under the FFDCA as amended by the Food Quality Protection Act 
    (FQPA) of 1996 (Pub. L. 104-170).
        On October 22, 1997, EPA established time-limited tolerances under 
    section 408(1)(6) of the FFDCA, as amended by the FQPA of 1996 for 
    residues of spinosad on fruiting vegetables (except cucurbits) group, 
    tomato paste, leafy vegetables (except Brassica vegetables) group, and 
    Brassica (cole), leafy vegetables group at 0.25, 0.50, 10.0, and 10.0 
    ppm, respectively (62 FR 54771) (FRL-5746-6). These tolerances were set 
    under the Section 18 emergency exemption provision of the FQPA and they 
    expire on September 30, 1998. These emergency exemption tolerances for 
    spinosad were granted to control Western Flower Thrips on fruiting 
    vegetables (excluding cucurbits) in the states of Florida, Georgia and 
    Arkansas, and to control beet armyworm on leafy vegetables (except 
    Brassica) and Brassica leafy vegetables in Arizona.
        In the Federal Register issues of December 24, 1996 (61 FR 67801) 
    (FRL-5578-2), October 8, 1997 (62 FR 52558) (FRL-5748-6), and March 4, 
    1998 (63 FR 10609) (FRL-5774-1), EPA issued notices pursuant to section 
    408 of the FFDCA, 21 U.S.C. 346a(e) announcing the filing of pesticide 
    petitions (PP) 7F4797, 7F4871, and 8F4942 for tolerances by DowElanco, 
    9330 Zionsville Road, Indianapolis IN 46268-1054. These notices 
    included a summary of the petitions prepared by DowElanco, the 
    registrant. There were no comments received in response to the notices 
    of filing.
        The petitions requested that 40 CFR 180.495 be amended by removing 
    the time limitation for the tolerance for residues of the insecticide 
    spinosad in or on cottonseed at 0.02 ppm and by establishing tolerances 
    in or on almonds at 0.02 ppm; almond hulls at 2.0 ppm; apples at 0.2 
    ppm; apple pomace, wet at 0.5 ppm; citrus fruits group at 0.3 ppm; 
    citrus pulp, dried at 0.5 ppm; citrus oil at 3.0 ppm; cotton gin 
    byproducts at 1.5 ppm; fruiting vegetables (except cucurbits) group at 
    0.4 ppm; leafy vegetables (except Brassica vegetables) group at 8.0 
    ppm; Brassica (cole), leafy vegetables, head and stem subgroup at 2.0 
    ppm; Brassica (cole), leafy vegetables, greens subgroup at 15.0 ppm; 
    fat of cattle, goats, hogs, horses, and sheep at 0.7 ppm; meat of 
    cattle, goats, hogs, horses, and sheep at 0.04 ppm; meat byproducts of 
    cattle, goats, hogs, horses, and sheep at 0.2 ppm; milk fat at 0.5 ppm; 
    and whole milk at 0.04 ppm. EPA determined that the requested 
    tolerances for fat of cattle, goats, hogs, horses, and sheep at 0.7 ppm 
    and Brassica (cole), leafy vegetables, greens subgroup at 15.0 ppm were 
    too high based on magnitude of the residue studies. EPA recommended 
    that the tolerances be set at 0.6 ppm and 10.0 ppm, respectively.
    
    I. Risk Assessment and Statutory Findings
    
        New section 408(b)(2)(A)(i) of the FFDCA allows EPA to establish a 
    tolerance (the legal limit for a pesticide chemical residue in or on a 
    food) only if EPA determines that the tolerance is ``safe.'' Section 
    408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable 
    certainty that no harm will result from aggregate exposure to the 
    pesticide chemical residue, including all anticipated dietary exposures 
    and all other exposures for which there is reliable information.'' This 
    includes exposure through drinking water and in residential settings, 
    but does not include occupational exposure. Section 408(b)(2)(C) 
    requires EPA to give special consideration to exposure of infants and 
    children to the pesticide chemical residue in establishing a tolerance 
    and to ``ensure that there is a reasonable certainty that no harm will 
    result to infants and children from aggregate exposure to the pesticide 
    chemical residue. . . .''
        EPA performs a number of analyses to determine the risks from 
    aggregate exposure to pesticide residues. First, EPA determines the 
    toxicity of pesticides based primarily on toxicological studies using 
    laboratory animals. These studies address many adverse health effects, 
    including (but not limited to) reproductive effects, developmental 
    toxicity, toxicity to the nervous system, and carcinogenicity. Second, 
    EPA examines exposure to the pesticide through the diet (e.g., food and 
    drinking water) and through exposures
    
    [[Page 18331]]
    
    that occur as a result of pesticide use in residential settings.
    
    A. Toxicity
    
        1. Threshold and non-threshold effects. For many animal studies, a 
    dose response relationship can be determined, which provides a dose 
    that causes adverse effects (threshold effects) and doses causing no 
    observed effects (the ``no-observed effect level'' or ``NOEL'').
        Once a study has been evaluated and the observed effects have been 
    determined to be threshold effects, EPA generally divides the NOEL from 
    the study with the lowest NOEL by an uncertainty factor (usually 100 or 
    more) to determine the Reference Dose (RfD). The RfD is a level at or 
    below which daily aggregate exposure over a lifetime will not pose 
    appreciable risks to human health. An uncertainty factor (sometimes 
    called a ``safety factor'') of 100 is commonly used since it is assumed 
    that people may be up to 10 times more sensitive to pesticides than the 
    test animals, and that one person or subgroup of the population (such 
    as infants and children) could be up to 10 times more sensitive to a 
    pesticide than another. In addition, EPA assesses the potential risks 
    to infants and children based on the weight of the evidence of the 
    toxicology studies and determines whether an additional uncertainty 
    factor is warranted. Thus, an aggregate daily exposure to a pesticide 
    residue at or below the RfD (expressed as 100 percent or less of the 
    RfD) is generally considered acceptable by EPA. EPA generally uses the 
    RfD to evaluate the chronic risks posed by pesticide exposure. For 
    shorter term risks, EPA calculates a margin of exposure (MOE) by 
    dividing the estimated human exposure into the NOEL from the 
    appropriate animal study. Commonly, EPA finds MOEs lower than 100 to be 
    unacceptable. This 100-fold MOE is based on the same rationale as the 
    100-fold uncertainty factor.
        Lifetime feeding studies in two species of laboratory animals are 
    conducted to screen pesticides for cancer effects. When evidence of 
    increased cancer is noted in these studies, the Agency conducts a 
    weight of the evidence review of all relevant toxicological data 
    including short-term and mutagenicity studies and structure activity 
    relationship. Once a pesticide has been classified as a potential human 
    carcinogen, different types of risk assessments (e.g., linear low dose 
    extrapolations or MOE calculation based on the appropriate NOEL) will 
    be carried out based on the nature of the carcinogenic response and the 
    Agency's knowledge of its mode of action.
        2. Differences in toxic effect due to exposure duration. The 
    toxicological effects of a pesticide can vary with different exposure 
    durations. EPA considers the entire toxicity data base, and based on 
    the effects seen for different durations and routes of exposure, 
    determines which risk assessments should be done to assure that the 
    public is adequately protected from any pesticide exposure scenario. 
    Both short and long durations of exposure are always considered. 
    Typically, risk assessments include ``acute,'' ``short-term,'' 
    ``intermediate term,'' and ``chronic'' risks. These assessments are 
    defined by the Agency as follows.
        Acute risk, by the Agency's definition, results from 1-day 
    consumption of food and water, and reflects toxicity which could be 
    expressed following a single oral exposure to the pesticide residues. 
    High end exposure to food and water residues are typically assumed.
        Short-term risk results from exposure to the pesticide for a period 
    of 1-7 days, and therefore overlaps with the acute risk assessment. 
    Historically, this risk assessment was intended to address primarily 
    dermal and inhalation exposure which could result, for example, from 
    residential pesticide applications. However, since enaction of FQPA, 
    this assessment has been expanded to include both dietary and non-
    dietary sources of exposure, and will typically consider exposure from 
    food, water, and residential uses when reliable data are available. In 
    this assessment, risks from average food and water exposure, and high-
    end residential exposure, are aggregated. High-end exposures from all 
    three sources are not typically added because of the very low 
    probability of this occurring in most cases, and because the other 
    conservative assumptions built into the assessment assure adequate 
    protection of public health. However, for cases in which high-end 
    exposure can reasonably be expected from multiple sources (e.g. 
    frequent and widespread homeowner use in a specific geographical area), 
    multiple high-end risks will be aggregated and presented as part of the 
    comprehensive risk assessment/characterization. Since the toxicological 
    endpoint considered in this assessment reflects exposure over a period 
    of at least 7 days, an additional degree of conservatism is built into 
    the assessment; i.e., the risk assessment nominally covers 1-7 days 
    exposure, and the toxicological endpoint/NOEL is selected to be 
    adequate for at least 7 days of exposure. (Toxicity results at lower 
    levels when the dosing duration is increased.)
        Intermediate-term risk results from exposure for 7 days to several 
    months. This assessment is handled in a manner similar to the short-
    term risk assessment.
        Chronic risk assessment describes risk which could result from 
    several months to a lifetime of exposure. For this assessment, risks 
    are aggregated considering average exposure from all sources for 
    representative population subgroups including infants and children.
    
    B. Aggregate Exposure
    
        In examining aggregate exposure, FFDCA section 408 requires that 
    EPA take into account available and reliable information concerning 
    exposure from the pesticide residue in the food in question, residues 
    in other foods for which there are tolerances, residues in groundwater 
    or surface water that is consumed as drinking water, and other non-
    occupational exposures through pesticide use in gardens, lawns, or 
    buildings (residential and other indoor uses). Dietary exposure to 
    residues of a pesticide in a food commodity are estimated by 
    multiplying the average daily consumption of the food forms of that 
    commodity by the tolerance level or the anticipated pesticide residue 
    level. The Theoretical Maximum Residue Contribution (TMRC) is an 
    estimate of the level of residues consumed daily if each food item 
    contained pesticide residues equal to the tolerance. In evaluating food 
    exposures, EPA takes into account varying consumption patterns of major 
    identifiable subgroups of consumers, including infants and children. 
    The TMRC is a ``worst case'' estimate since it is based on the 
    assumptions that food contains pesticide residues at the tolerance 
    level and that 100% of the crop is treated by pesticides that have 
    established tolerances. If the TMRC exceeds the RfD or poses a lifetime 
    cancer risk that is greater than approximately one in a million, EPA 
    attempts to derive a more accurate exposure estimate for the pesticide 
    by evaluating additional types of information (anticipated residue data 
    and/or percent of crop treated data) which show, generally, that 
    pesticide residues in most foods when they are eaten are well below 
    established tolerances.
    
    II. Aggregate Risk Assessment and Determination of Safety
    
        Consistent with section 408(b)(2)(D), EPA has reviewed the 
    available scientific data and other relevant information in support of 
    this action.
    
    [[Page 18332]]
    
     EPA has sufficient data to assess the hazards of spinosad and to make 
    a determination on aggregate exposure, consistent with section 
    408(b)(2), for tolerances for residues of spinosad on almonds at 0.02 
    ppm; almond hulls at 2.0 ppm; apples at 0.2 ppm; apple pomace, wet at 
    0.5 ppm; citrus fruits group at 0.3 ppm; citrus pulp, dried at 0.5 ppm; 
    citrus oil at 3.0 ppm; cottonseed at 0.02 ppm; cotton gin byproducts at 
    1.5 ppm; fruiting vegetables (except cucurbits) group at 0.4 ppm; leafy 
    vegetables (except Brassica vegetables) group at 8.0 ppm; Brassica 
    (cole), leafy vegetables, head and stem subgroup at 2.0 ppm; Brassica 
    (cole), leafy vegetables, greens subgroup at 10.0 ppm; fat of cattle, 
    goats, hogs, horses, and sheep at 0.6 ppm; meat and meat byproducts of 
    cattle, goats, hogs, horses, and sheep at 0.04 ppm; milk fat at 0.5 
    ppm; and whole milk at 0.04 ppm. EPA's assessment of the dietary 
    exposures and risks associated with establishing the tolerance follows.
    
    A. Toxicological Profile
    
        EPA has evaluated the available toxicity data and considered its 
    validity, completeness, and reliability as well as the relationship of 
    the results of the studies to human risk. EPA has also considered 
    available information concerning the variability of the sensitivities 
    of major identifiable subgroups of consumers, including infants and 
    children. The nature of the toxic effects caused by spinosad are 
    discussed below.
        1. Acute toxicity studies with technical spinosad (88% - 90.4%): 
    Oral LD50 in the rat is > 5,000 milligram/kilogram (mg/kg) 
    for males and females - Toxicity Category IV; dermal LD50 in 
    the rat is >2,800 mg/kg for males and females - Toxicity Category III; 
    inhalation LC50 in the rat is >5.18 mg/L - Toxicity Category 
    IV; primary eye irritation in the rabbit (slight conjunctival 
    irritation) - Toxicity Category IV; primary dermal irritation in the 
    rabbit (no erythema and edema) - Toxicity Category IV. Spinosad is not 
    a sensitizer.
        2. Acute toxicity studies with the end-use (44% formulation) 
    product for spinosad: Oral LD50 in the rat is >5,000 mg/kg 
    for males and females - Toxicity Category IV; dermal LD50 in 
    the rat is >2,800 mg/kg for males and females - Toxicity Category III; 
    inhalation LC50 in the rat is >5 mg/L - Toxicity Category 
    IV; primary eye irritation in the rabbit (slight conjunctival 
    irritation) - Toxicity Category IV; primary dermal irritation in the 
    rabbit (slight transient erythema and edema) - Toxicity Category IV; 
    not a sensitizer.
        3. In a subchronic feeding study in rats, the no-observed adverse 
    effect level (NOAEL) was 33.9 and 38.8 mg/kg/day for males and females, 
    respectively. The lowest observed effect level (LOEL) was 68.5 and 78.1 
    mg/kg/day for males and females, respectively based on decreased body 
    weight gain, anemia, and vacuolation in multiple organs (kidney, liver, 
    heart, spleen, adrenals, and thyroid).
        4. In a subchronic feeding study in mice, the NOEL was 7.5 mg/kg/
    day and the LOEL was 22.5 mg/kg/day based on cytoplasmic vacuolation in 
    multiple organs (kidney, liver, heart, stomach, lymphoid organs, and 
    ovary).
        5. In a subchronic feeding study in dogs, the NOEL was 4.89 and 
    5.38 mg/kg/day for males and females, respectively. The LOEL was 9.73 
    mg/kg/day and 10.5 mg/kg/day based on decreased mean body weights and 
    food consumption, and anemia.
        6. In a 21-day dermal study in rats, the NOEL for systemic effects 
    was > 1,000 mg/kg/day (limit dose). No systemic toxicity was observed 
    at any dose tested.
        7. In a chronic feeding study in dogs, the NOEL was 2.68 mg/kg/day. 
    The LOEL was 8.22 mg/kg/day based on increased liver enzymes (ALT, 
    AST), triglycerides; vacuolated cells (parathyroid), and arteritis.
        8. In a carcinogenicity study in mice, the NOEL was 11.4 mg/kg/day. 
    The LOEL was 50.9 mg/kg/day based on decreased body weight gains, 
    increased mortality, hematologic effects, increased thickening of the 
    gastric mucosa, and histologic changes in the stomach of males.
        9. In a chronic feeding/carcinogenicity/neurotoxicity study in 
    rats, the NOEL (systemic) was 9.5 and 12.0 mg/kg/day for males and 
    females, respectively. The LOEL (systemic) was 24.1 and 30.3 mg/kg/day 
    for males and females, respectively based on vacuolation of epithelial 
    follicular cells of the thyroid. The neurological NOEL was 46 and 57 
    mg/kg/day for males and females, respectively. The neurological LOEL 
    was not determined.
        10. In a developmental study in rabbits, the maternal NOEL was 
    50 mg/kg/day. The maternal LOEL was not established. The 
    developmental NOEL was 50 mg/kg/day. The developmental LOEL 
    was not established.
        11. In a developmental study in rats, the maternal NOEL was >200 
    mg/kg/day. The maternal LOEL was not established. The developmental 
    NOEL was >200 mg/kg/day. The developmental LOEL was not established.
        12. In a two-generation reproduction toxicity study in rats, the 
    systemic NOEL was 10 mg/kg/day. The systemic LOEL was 100 mg/kg/day 
    based on increased organ weights (heart, liver, kidney, spleen, 
    thyroid), histopath lesions in the lungs and mesenteric lymph nodes, 
    stomach (F), and prostate. The reproductive NOEL was 10 mg/kg/day. The 
    reproductive LOEL was 100 mg/kg/day based on decreased litter size, 
    decreased pup survival, decreased body weight, increased incidence of 
    dystocia and/or vaginal bleeding post-partum with associated increased 
    mortality of dams.
        13. Studies on gene mutation and other genotoxic effects: In a Gene 
    Mutation Assay (mouse forward mutation) there was no forward mutation 
    induction in mouse lymphoma L5178Y Tk +/- cells at concentrations of 0, 
    1, 5, 10, 15, 20, or 25 g/ml without metabolic activation or 
    at concentrations of 15 through 50 g/ml with metabolic 
    activation. In a Structural Chromosomal Aberration Assay in vitro there 
    was no increase in the number of CHO (chinese hamster ovary) cells with 
    chromosomal aberrations at concentratioins from 20 to 35 g/ml 
    (without activation) or concentrations from 100 to 500 g/ml 
    (with activation). In a Micronucleus Test in mice, there was no 
    increase in the frequencey of micronuclei in bone marrow cells from 
    mice treated at concentratioins from 500 to 2,000 g/ml for two 
    days. In Other Genotoxicity Assays, unscheduled DNA synthesis was not 
    induced in adult rat hepatocytes in vitro at concentrations of 0.01 to 
    5 g/ml tested.
        14. The results of three metabolism studies are as follows: (i) 
    Approximately 95% of technical spinosad was eliminated by 24 hours 
    mainly in the urine (34%), bile (36%), and tissues and carcass (21%). 
    Metabolites include the glutathione conjugates of the unchanged form as 
    well as N- and O-demethylated forms of XDE-105 (Factor D). (ii) At 100 
    mg/kg/dose, the radiolabeled XDE-105 (Factor D) was primarily excreted 
    in the feces (68%) after 24-hours. The absorption, distribution, and 
    elimination of 14C-XDE-105 (Factor A) demonstrated no appreciable 
    differences based on dose or repeated dosing. (iii) At high (100 mg/kg) 
    doses, there are no major differences in the bioavailability, routes or 
    rates of excretion or metabolism of 14C-XDE-105 (Factor A) following 
    oral administration.
        15. In an acute neurotoxicity study, groups of Fischer 334 rats 
    (10/sex/dose) received a single oral (gavage) administration of 
    spinosad (87.9%) at dose levels of 0, 200, 630, or 2,000 mg/
    
    [[Page 18333]]
    
    kg. There were no effects on neurobehavioral endpoints or 
    histopathology of the nervous system. For neurotoxicity, the NOEL was 
     2,000 mg/kg/day, highest dose tested (HDT). A LOEL was not 
    established.
        16. In a subchronic neurotoxicity study, groups of Fischer 344 rats 
    (10/sex/dose) were administered diets containing spinosad at levels of 
    0, 0.003, 0.006, 0.012, or 0.06% (0, 2.2, 4.3, 8.6, or 42.7 mg/kg/day 
    for males and 2.6, 5.2, 10.4, or 52.1 mg/kg/day for females, 
    respectively). There were no effects on neurobehavior endpoints or 
    histopathology of the nervous system. For neurotoxicity, the NOEL was 
     42.7 and 52.1 mg/kg/day in males and females, 
    respectively (HDT).
        17. In the 2-year chronic neurotoxicity study, groups of Fischer 
    344 rats (65/sex/dose) received diets containing spinosad at dose 
    levels of 0, 0.005, 0.02, 0.05, or 0.1% (0, 2.4, 9.5, 24.1, or 49.4 mg/
    kg/day for males and 0, 3.0, 12.0, 30.3, or 62.2 mg/kg/day for females, 
    respectively). Neurobehavioral testing performed at 3, 6, 9, and 12 
    months of study was negative, and histopathological evaluation of 
    perfused tissues at study termination did not identify pathology of the 
    central or peripheral nervous system. There was no evidence of 
    neurotoxicity. For neuropathology, the NOEL was 0.1% ( 46 
    mg/kg/day for males and 57 mg/kg/day for females (HDT).
    
    B. Toxicological Endpoints
    
        1. Acute toxicity. EPA did not select a dose and endpoint for an 
    acute dietary risk assessment due to the lack of toxicological effects 
    attributable to a single exposure (dose) in studies available in the 
    data base including oral developmental toxicity studies in rats and 
    rabbits. In the acute neurotoxicity study the NOEL was 2,000 
    mg/kg/day.
         2. Short - (1 day to 7 days), intermediate- (1 week to several 
    months), and chronic - term occupational and residential dermal and 
    inhalation toxicity. EPA did not select a dose or endpoint for short-, 
    intermediate and long-term dermal risk assessments because (i) lack of 
    appropriate endpoints; (ii) the combination of molecular structure and 
    size as well as the lack of dermal or systemic toxicity at 2,000 mg/kg/
    day in a 21-day dermal toxicity study in rats which indicates the lack 
    of dermal absorption; and (iii) the lack of long-term exposure based on 
    the current use pattern. Therefore, a dermal risk assessment is not 
    required. EPA also determined that based on the current use pattern and 
    exposure scenario, an inhalation risk assessment is not required.
        3. Chronic toxicity. EPA has established the RfD for spinosad at 
    0.027 mg/kg/day. This RfD is based on a chronic toxicity study in dogs 
    using a NOEL of 2.68 mg/kg/day. The LOEL was 8.46 mg/kg/day based on 
    vacuolation in glandular cells (parathyroid) and lymphatic tissues, 
    arteritis and increases in serum enzymes such as alanine 
    aminotransferase, and aspartate aminotransferase, and triglyceride 
    levels in dogs fed spinosad in the diet at dose levels of 1.44, 2.68, 
    or 8.46 mg/kg/day for 52 weeks. A 100-fold uncertainty factor (UF) was 
    applied to the NOEL of 2.68 mg/kg/day to account for inter- and intra-
    species variation.
        EPA determined that the 10X factor to account for enhanced 
    sensitivity of infants and children (as required by FQPA) should be 
    removed. Thus, an uncertainty factor of 100 is adequate and the RfD 
    remains at 0.027 mg/kg/day.
        The FQPA factor is removed because: (i) The data provided no 
    indication of increased susceptibility of rats or rabbits to in utero 
    and/or post-natal exposure to spinosad. In the prenatal developmental 
    toxicity studies in rats and rabbits and the two-generation 
    reproduction study in rats, effects in the offspring were observed only 
    at or below treatment levels which resulted in evidence of parental 
    toxicity. (ii) No neurotoxic signs have been observed in any of the 
    standard required studies conducted. (iii) The toxicology data base is 
    complete and there are no data gaps.
        4. Carcinogenicity. There is no evidence of carcinogenicity in 
    studies in either the mouse or rat.
    
    C. Exposures and Risks
    
        1. From food and feed uses. Tolerances have been established (40 
    CFR 180.495) for the residues of spinosad in or on cottonseed at 0.02 
    ppm (to expire on 11/15/99). Time-limited tolerances for Section 18 
    emergency exemptions are established under 40 CFR 180.495 for residues 
    of spinosad in or on Brassica (cole) leafy vegetables at 10 ppm, 
    fruiting vegetables (except cucurbit vegetables) at 0.25 ppm, leafy 
    vegetables (except Brassica vegetables) at 10 ppm, and tomato paste at 
    0.5 ppm. Risk assessments were conducted by EPA to assess dietary 
    exposures and risks from spinosad as follows:
        i.  Acute exposure and risk. Acute dietary risk assessments are 
    performed for a food-use pesticide if a toxicological study has 
    indicated the possibility of an effect of concern occurring as a result 
    of a one day or single exposure. No acute toxicological endpoints were 
    identified for spinosad due to the lack of toxicological effects 
    attributable to a single exposure (dose). Therefore, the Agency 
    concludes that there is a reasonable certainty of no harm from acute 
    dietary exposure.
        ii. Chronic exposure and risk. The RfD used for the chronic dietary 
    analysis is 0.027 mg/kg/day. In conducting this chronic dietary risk 
    assessment, EPA made very conservative assumptions: 100% of citrus, 
    almonds, apples, fruiting (except cucurbit) vegetables, Brassica leafy 
    vegetables, leafy vegetables, cottonseed, and ruminant commodities 
    having spinosad tolerances will contain spinosad residues and those 
    residues will be at the level of the established tolerance. This 
    results in an overestimate of human dietary exposure. This chronic 
    dietary risk assessment used 10 ppm tolerances for the leafy vegetables 
    (except Brassica vegetables) crop group and for the Brassica leafy 
    vegetables head and stem subgroup from section 18 tolerances that were 
    established last year. For the section 3 registrations on these groups, 
    EPA has recommended tolerances of 8 ppm (leafy vegetables) and 2 ppm 
    (Brassica head and stem leafy vegetables). The use pattern for these 
    section 18 registrations is identical to the section 3 registrations 
    proposed in this risk assessment, but due to an incomplete data base at 
    the time the Section 18s were reviewed, the tolerances were set high 
    which resulted in a conservative risk assessment. With this action, 
    these section 18 tolerances are replaced by the new section 3 
    tolerances. Thus, in making a safety determination for this tolerance, 
    EPA is taking into account this conservative exposure assessment.
        The existing spinosad tolerances (published, pending, and including 
    the Section 18 tolerances) result in a Theoretical Maximum Residue 
    Contribution (TMRC) that is equivalent to the following percentages of 
    the RfD: U.S. Population (24% of RfD); Nursing Infants (<1 year="" old)(="" 8%="" of="" rfd);="" non-nursing="" infants=""><1 year="" old)="" (24%="" of="" rfd);="" children="" (1-6="" years="" old)="" (34%="" of="" rfd);="" children="" (7-12="" years="" old)="" (29%="" of="" rfd);="" northeast="" region="" (25%="" of="" rfd);="" western="" region="" (27%="" of="" rfd);="" non-="" hispanic="" blacks="" (27%="" of="" rfd);="" non-hispanic="" others="" (37%="" of="" rfd);="" females="" 13+="" years,="" nursing="" (27%="" of="" rfd).="" 2.="" from="" drinking="" water.="" the="" agency="" has="" determined="" that="" spinosyns="" factor="" a="" and="" factor="" d="" are="" immobile="" in="" soil="" and="" will="" not="" leach="" into="" ground="" water.="" based="" on="" structure/activity="" relationships,="" the="" agency="" concluded="" that="" the="" spinosad="" metabolites/fermentation="" impurities="" [[page="" 18334]]="" (spinosyns="" factor="" b,="" factor="" b="" of="" d,="" factor="" k,="" and="" other="" related="" factors)="" were="" of="" no="" more="" toxicological="" concern="" than="" the="" two="" parent="" compounds="" (spinosyns="" factor="" a="" and="" factor="" d)="" and="" therefore,="" only="" these="" were="" considered="" in="" the="" drinking="" water="" assessment.="" epa="" used="" the="" ``interim="" approach="" for="" addressing="" drinking="" water="" exposure="" in="" tolerance="" decision="" making''="" issued="" on="" november="" 17,="" 1997.="" thus,="" the="" przm/exams="" models="" were="" run="" to="" produce="" estimates="" of="" spinosad="" in="" surface="" water.="" the="" primary="" use="" of="" these="" models="" is="" to="" provide="" a="" screen="" for="" sorting="" out="" pesticides="" for="" which="" opp="" has="" a="" high="" degree="" of="" confidence="" that="" the="" true="" levels="" of="" the="" pesticide="" in="" drinking="" water="" will="" be="" less="" than="" the="" human="" health="" drinking="" water="" levels="" of="" concern="" (dwlocs).="" a="" human="" health="" dwloc="" is="" the="" concentration="" of="" a="" pesticide="" in="" drinking="" water="" which="" would="" result="" in="" acceptable="" aggregate="" risk,="" after="" having="" already="" factored="" in="" all="" food="" exposures="" and="" other="" non-occupational="" exposures="" for="" which="" opp="" has="" reliable="" data.="" przm/exams="" was="" used="" to="" conduct="" a="" tier="" 2="" surface="" water="" analysis.="" the="" tier="" 2="" estimated="" drinking="" water="" concentration="" (eec)="" of="" spinosad="" from="" surface="" water="" sources="" is="" not="" likely="" to="" exceed="" 0.059="">g/L from use on apples, 0.092 g/L from use on 
    Brassica vegetables, 0.065 g/L from use on cotton, and 0.075 
    g/L from use on citrus.
        i. Acute exposure and risk. Because no acute dietary endpoint was 
    determined, the Agency concludes that there is a reasonable certainty 
    of no harm from acute exposure from drinking water.
        ii. Chronic exposure and risk. Based on the chronic dietary (food) 
    exposure and using default body weights and water consumption figures, 
    chronic drinking water levels of concern (DWLOC) for drinking water 
    were calculated. The chronic drinking water exposure and risk estimates 
    are 0.019890 mg/kg/day (690 g/L DWLOC) for the overall U.S. 
    population; 0.01896 mg/kg/day (570 g/L DWLOC) for females 13+ 
    years, nursing; and 0.016865 mg/kg/day (170 g/L DWLOC) for 
    children age 1-6 years.
        3. From non-dietary exposure. There are no current residential uses 
    for spinosad. However, the proposed use of a 0.5% spinosad product on 
    structural lumber may have residential uses. This product is injected 
    into drilled holes and then sealed after treatment. Due to the lack of 
    toxicity endpoints (hazard) and minimal contact with the active 
    ingredient during and after application, exposure to residential 
    occupants is not expected.
        4. Cumulative exposure to substances with common mechanism of 
    toxicity. Spinosad has not yet been grouped with any other insecticides 
    into a class.
        Section 408(b)(2)(D)(v) requires that, when considering whether to 
    establish, modify, or revoke a tolerance, the Agency consider 
    ``available information'' concerning the cumulative effects of a 
    particular pesticide's residues and ``other substances that have a 
    common mechanism of toxicity.'' The Agency believes that ``available 
    information'' in this context might include not only toxicity, 
    chemistry, and exposure data, but also scientific policies and 
    methodologies for understanding common mechanisms of toxicity and 
    conducting cumulative risk assessments. For most pesticides, although 
    the Agency has some information in its files that may turn out to be 
    helpful in eventually determining whether a pesticide shares a common 
    mechanism of toxicity with any other substances, EPA does not at this 
    time have the methodologies to resolve the complex scientific issues 
    concerning common mechanism of toxicity in a meaningful way. EPA has 
    begun a pilot process to study this issue further through the 
    examination of particular classes of pesticides. The Agency hopes that 
    the results of this pilot process will increase the Agency's scientific 
    understanding of this question such that EPA will be able to develop 
    and apply scientific principles for better determining which chemicals 
    have a common mechanism of toxicity and evaluating the cumulative 
    effects of such chemicals. The Agency anticipates, however, that even 
    as its understanding of the science of common mechanisms increases, 
    decisions on specific classes of chemicals will be heavily dependent on 
    chemical specific data, much of which may not be presently available.
        Although at present the Agency does not know how to apply the 
    information in its files concerning common mechanism issues to most 
    risk assessments, there are pesticides as to which the common mechanism 
    issues can be resolved. These pesticides include pesticides that are 
    toxicologically dissimilar to existing chemical substances (in which 
    case the Agency can conclude that it is unlikely that a pesticide 
    shares a common mechanism of activity with other substances) and 
    pesticides that produce a common toxic metabolite (in which case common 
    mechanism of activity will be assumed).
        EPA does not have, at this time, available data to determine 
    whether spinosad has a common mechanism of toxicity with other 
    substances or how to include this pesticide in a cumulative risk 
    assessment. Unlike other pesticides for which EPA has followed a 
    cumulative risk approach based on a common mechanism of toxicity, 
    spinosad does not appear to produce a toxic metabolite produced by 
    other substances. For the purposes of these tolerance actions, 
    therefore, EPA has not assumed that spinosad has a common mechanism of 
    toxicity with other substances.
    
    D. Aggregate Risks and Determination of Safety for U.S. Population
    
        Chronic risk. Using the TMRC exposure assumptions described in Unit 
    I.B. of this Preamble, EPA has concluded that aggregate exposure to 
    spinosad from food will utilize 24% of the RfD for the U.S. population. 
    For the most highly exposed populations subgroup, children (1-6 years 
    old) and non-Hispanic others, chronic dietary (food only) exposure 
    occupies 34% and 37% of the RfD, respectively. This is a conservative 
    risk estimate for reasons described above. EPA generally has no concern 
    for exposures below 100% of the RfD because the RfD represents the 
    level at or below which daily aggregate dietary exposure over a 
    lifetime will not pose appreciable risks to human health. The chronic 
    DWLOC for the infants and children subgroup is 170 ppb. The chronic 
    modeling estimates (EECs) for spinosad residues in surface water are as 
    high as 0.092 ppb from use on Brassica leafy vegetables. The maximum 
    estimated concentrations of spinosad in surface water are less than 
    EPA's levels of concern for spinosad in drinking water as a 
    contribution to chronic aggregate exposure. Taking into account present 
    uses and uses proposed in this risk assessment, EPA concludes with 
    reasonable certainty that residues of spinosad in drinking water (when 
    considered along with other sources of exposure for which EPA has 
    reliable data ) would not result in unacceptable levels of aggregate 
    human health risk at this time. Therefore, the Agency concludes that 
    there is a reasonable certainty that no harm will result from chronic 
    aggregate exposure to spinosad residues from food and water.
        No dermal or inhalation endpoints were identified. Due to the 
    nature of the non-dietary use, EPA believes that the use of spinosad in 
    treating structural lumber will not result in any exposure through the 
    oral route. Therefore, the chronic aggregate risk is the sum of food 
    and water.
    
    [[Page 18335]]
    
    E. Aggregate Cancer Risk for U.S. Population
    
        The RfD Committee determined that there is no evidence of 
    carcinogenicity in studies in either the mouse or rat. Therefore, a 
    carcinogenic risk assessment is not required.
    
    F. Aggregate Risks and Determination of Safety for Infants and Children
    
        1. Safety factor for infants and children-- i. In general. In 
    assessing the potential for additional sensitivity of infants and 
    children to residues of spinosad, EPA considered data from 
    developmental toxicity studies in the rat and rabbit and a two-
    generation reproduction study in the rat. The developmental toxicity 
    studies are designed to evaluate adverse effects on the developing 
    organism resulting from pesticide exposure during prenatal development 
    to one or both parents. Reproduction studies provide information 
    relating to effects from exposure to the pesticide on the reproductive 
    capability of mating animals and data on systemic toxicity.
        FFDCA section 408 provides that EPA shall apply an additional 
    tenfold margin of safety for infants and children in the case of 
    threshold effects to account for pre-and post-natal toxicity and the 
    completeness of the database unless EPA determines that a different 
    margin of safety will be safe for infants and children. Margins of 
    safety are incorporated into EPA risk assessments either directly 
    through use of a MOE analysis or through using uncertainty (safety) 
    factors in calculating a dose level that poses no appreciable risk to 
    humans. EPA believes that reliable data support using the standard MOE 
    and uncertainty factor (usually 100 for combined inter- and intra-
    species variability) and not the additional tenfold MOE/uncertainty 
    factor when EPA has a complete data base under existing guidelines and 
    when the severity of the effect in infants or children or the potency 
    or unusual toxic properties of a compound do not raise concerns 
    regarding the adequacy of the standard MOE/safety factor.
        ii. Developmental toxicity studies. a. In a prenatal developmental 
    toxicity study, groups of pregnant Sprague-Dawley rats (30/group) 
    received oral (gavage) administration of spinosad (88.6%) in aqueous 
    0.5% methycellulose at dose levels of 0,10, 50, 200 mg/kg/day during 
    gestation days 6 through 17. For maternal toxicity, the NOEL was 
    200 mg/kg/day (HDT); a LOEL was not established. Marginal 
    maternal toxicity was reported at this dose level (decreased body 
    weight gain). Based upon the results of a range-finding study, which 
    showed maternal toxicity (body weight and food consumption decreases at 
    100 and 300 mg/kg/day), the dose level of 200 mg/kg/day in the main 
    study was considered adequate. For developmental toxicity, the NOEL was 
    >200 mg/kg/day; a LOEL was not established. In the range-finding study, 
    fetal body weight decrements occurred at 300 mg/kg/day.
        b. In a prenatal developmental toxicity study, groups of pregnant 
    New Zealand White rabbits (20/group) received oral (gavage) 
    administration of spinosad (88.6%) in 0.5% aqueous methyl cellulose at 
    doses of 0, 2.5, 10, or 50 mg/kg/day during gestation days 7 through 
    19. For maternal toxicity, the NOEL was 50 mg/kg/day (HDT); 
    a LOEL was not established. At this dose, slight body weight loss was 
    observed in the first few days of dosing, but this finding was not 
    supported by other signs. In the range-finding study, inanition was 
    observed at doses of 100, 200, and 400 mg/kg/day, with significant 
    decreases in body weight gain during dosing. All does at these dose 
    levels were sacrificed prior to scheduled termination; no fetal data 
    were available. No evidence of developmental toxicity was noted. For 
    developmental toxicity, the NOEL was 50 mg/kg/day; a LOEL 
    was not established. (No fetal effects were noted for fetuses of the 
    range-finding study at doses up to 50 mg/kg/day).
        iii. Reproductive toxicity study. In a two-generation reproduction 
    study, groups of Sprague-Dawley rats (30/sex/group) received diets 
    containing spinosad (88%) at dose levels of 0, 0.005, 0.02, or 0.2% (3, 
    10, or 10 mg/kg/day, respectively) for two successive generations. For 
    parental systemic toxicity, the NOEL was 0.02% (10 mg/kg/day) and the 
    LOEL was 0.2% (100 mg/kg/day), based on increased heart, kidney, liver, 
    spleen, and thyroid weights (both sexes), histopathology in the spleen 
    and thyroid (both sexes), heart and kidney (males), and histopathologic 
    lesions in the lungs and mesenteric lymph nodes (both sexes), stomach 
    (females), and prostate. For offspring toxicity, the NOEL was 0.02% (10 
    mg/kg/day) and the LOEL was 0.2% (100 mg/kg/day) based on decreased 
    litter size, survival (F2), and body weights. Reproductive effects at 
    that dose level included increased incidence of dystocia and/or vaginal 
    bleeding after parturition with associated increase in mortality of 
    dams.
        iv. Neurotoxicity. a. In an acute neurotoxicity study, groups of 
    Fischer 344 rats (10/sex/dose) received a single oral (gavage) 
    administration of spinosad (87.9%) at dose levels of 0, 200, 630, or 
    2,000 mg/kg. There were no effects on neurobehavioral endpoints or 
    histopathology of the nervous system. For neurotoxicity, the NOEL was 
    >2,000 mg/kg (HDT); a LOEL was not established.
        b. In a subchronic neurotoxicity study, groups of Fisher 344 rats 
    (10/sex/dose) were administered diets containing spinosad at levels of 
    0, 0.003, 0.006, 0.012, or 0.06% (0, 2.2, 4.3, 8.6, or 42.7 mg/kg/day 
    for males and 2.6, 5.2, 10.4, or 52.1 mg/kg/day for females, 
    respectively). There were no effects on neurobehavioral endpoints or 
    histopathology of the nervous system. For neurotoxicity, the NOEL was 
    42.7 for males and 52.1 mg/kg/day for females 
    (HDT).
        c. In the 2-year chronic toxicity study, groups of Fischer 344 rats 
    (65/sex/dose) received diets containing spinosad at dose levels of 0, 
    0.005, 0.02, 0.05, or 0.1% (0, 2.4, 9.5, 24.1, or 49.4 mg/kg/day for 
    males and 0, 3.0, 12.0, 30.3, or 62.2 mg/kg/day for females, 
    respectively). Neurobehavioral testing performed at 3, 6, 9, and 12 
    months of study was negative, and histopathological evaluation of 
    perfused tissues at study termination did not identify pathology of the 
    central or peripheral nervous system. There was no evidence of 
    neurotoxicity. For neuropathology, the NOEL was 0.1% (>49.4 mg/kg/day 
    for males and 62.8 mg/kg/day for females).
        v. Pre- and post-natal sensitivity. There was no increased 
    susceptibility to rats or rabbits following in utero and/or postnatal 
    exposure to spinosad.
         vi. Conclusion. The data provided no indication of increased 
    susceptibility of rats or rabbits to in utero and/or postnatal exposure 
    to spinosad. In the prenatal developmental toxicity studies in rats and 
    rabbits and the two-generation reproduction study in rats, effects in 
    the offspring were observed only at or below treatment levels which 
    resulted in evidence of parental toxicity. In addition, all 
    neurotoxicity studies were negative for effects on the central or 
    peripheral nervous system.
        EPA determined that the 10X factor to account for enhanced 
    sensitivity of infants and children (as required by FQPA) should be 
    removed. The FQPA factor is removed because:
        (i) The data provided no indication of increased susceptibility of 
    rats or rabbits to in utero and/or post natal exposure to spinosad. In 
    the prenatal developmental toxicity studies in rats and rabbits and the 
    two-generation reproduction study in rats, effects in the offspring 
    were observed only at or below treatment
    
    [[Page 18336]]
    
    levels which resulted in evidence of parental toxicity.
        (ii) No neurotoxic signs have been observed in any of the standard 
    required studies conducted.
        (iii) The toxicology data base is complete and there are no data 
    gaps.
        2. Acute risk. An acute risk assessment is not required because no 
    acute toxicological endpoints were identified for spinosad.
        3. Chronic risk. Using the conservative exposure assumptions 
    described above, EPA has concluded that aggregate exposure to spinosad 
    from food will utilize 34% of the RfD for children age 1-6 years old. 
    EPA generally has no concern for exposures below 100% of the RfD 
    because the RfD represents the level at or below which daily aggregate 
    dietary exposure over a lifetime will not pose appreciable risks to 
    human health. EPA concludes that there is a reasonable certainty that 
    no harm will result to infants and children from aggregate exposure to 
    spinosad residues.
    
    G. Endocrine Disruption
    
        EPA is required to develop a screening program to determine whether 
    certain substances (including all pesticides and inerts) ``may have an 
    effect in humans that is similar to an effect produced by a naturally 
    occurring estrogen, or such other endocrine effect...'' The Agency is 
    currently working with interested stakeholders, including other 
    government agencies, public interest groups, industry and research 
    scientists in developing a screening and testing program and a priority 
    setting scheme to implement this program. Congress has allowed 3 years 
    from the passage of FQPA (August 3, 1999) to implement this program. At 
    that time, EPA may require further testing of this active ingredient 
    and end use products for endocrine disrupter effects.
    
    III. Other Considerations
    
    A. Metabolism In Plants and Animals
    
        EPA has reviewed the results of plant metabolism studies (apples, 
    cabbage, cotton, tomatoes, turnips) and livestock metabolism studies 
    (goat and hen). The metabolism of spinosad in plants and animals is 
    adequately understood for the purposes of these tolerances. Based on 
    structure/activity relationships, EPA concluded that the spinosad 
    metabolites/fermentation impurities (spinosyns Factor B, Factor B or D, 
    Factor K, and other related Factors) were of no more toxicological 
    concern than the two parent compounds (spinosyns Factor A and Factor 
    D).
        EPA focused on the following data/information: the overall low 
    toxicity of spinosad; the low levels of metabolites/fermentation 
    impurities present; and that spinosad appears to photodegrade rapidly 
    and become incorporated into the general carbon pool. EPA concluded 
    that only 2 parent compounds (spinosyns Factor A and Factor D) need to 
    be included in the tolerance expression and used for dietary risk 
    assessment purposes.
    
    B. Analytical Enforcement Methodology
    
        Method GRM 94.02 (method for determination of spinosad residues in 
    cottonseed and related commodities using HPLC/UV) underwent successful 
    independent lab validation and EPA lab validation and has been 
    submitted to FDA for inclusion in PAM II as Method I. Additional 
    methods have been submitted for other crop matrices (leafy vegetables - 
    GRM 95.17; citrus - GRM 96.09; tree nuts - GRM 96.14; fruiting 
    vegetables - GRM 95.04; and cotton gin byproducts - GRM 94.02.S1). All 
    of these methods are essentially similar to GRM 94.02 and have been 
    submitted to FDA for inclusion in PAM II as letter methods. These 
    methods are adequate for regulation of the tolerance expression.
        Method RES 94094 (method for determination of spinosad residues in 
    ruminant commodities using HPLC/UV) underwent successful independent 
    lab validation and EPA lab validation. This method is adequate for 
    regulation of the tolerance expression.
        Method RES 95114 (method for determination of spinosad residues in 
    ruminant commodities using immunoassay) underwent successful 
    independent lab validation and EPA lab validation.This method is 
    adequate for regulation of the tolerance expression.
    
    C. Magnitude of Residues
    
        Adequate residue data were provided to support tolerances of 0.02 
    ppm for almonds; 2.0 ppm for almond hulls; 0.2 for apples; 2.0 ppm for 
    the head and stem subgroup of the Brassica leafy vegetables crop group; 
    10.0 ppm for the greens subgroup of the Brassica leafy vegetables crop 
    group; 0.3 ppm for the citrus fruits crop group; 0.02 ppm on 
    cottonseed; 1.5 ppm on cotton gin byproducts; 0.4 ppm for the fruiting 
    vegetables (except cucurbit vegetables) crop group; and, 8.0 ppm for 
    the leafy vegetables (except Brassica vegetables ) crop group.
        Processing data provided for apples indicated concentration of 
    residues in wet apple pomace. Based on the concentration factor of 5.6X 
    and the highest average field trial (HAFT) residue level of 0.089 ppm 
    for apples, the data support a tolerance of 0.5 ppm for wet apple 
    pomace.
        Processing data provided for citrus indicated concentration of 
    residues in dried citrus pulp and citrus oil. Based on the 
    concentration factor of 2.4X in dried pulp and 12.7X in oil and the 
    highest average field trial (HAFT) residue level of 0.200 ppm for 
    oranges, the data support tolerances of 0.5 ppm for dried citrus pulp 
    and 3.0 ppm for citrus oil.
        Processing data provided for cottonseed did not indicate any 
    concentration of residues in meal or hulls. No tolerances are required 
    for processed cotton commodities.
        There are no livestock feedstuffs associated with Brassica leafy 
    vegetables, fruiting vegetables, and leafy vegetables.
        A ruminant feeding study was submitted. Based on the results of 
    this study, the data support the following tolerances: fat (or cattle, 
    goats, hogs, horses, and sheep) at 0.6 ppm; meat (of cattle, goats, 
    hogs, horses, and sheep) at 0.04 ppm; meat byproducts (of cattle, 
    goats, hogs, horses, and sheep) at 0.2 ppm; milk fat at 0.5 ppm; and 
    whole milk at 0.04 ppm. These levels are adequate for the feed items 
    associated with all existing and proposed uses covered in this risk 
    assessment.
        Requirements for a poultry feeding study have been waived based on 
    the minimal impact of spinosad residues in a typical poultry diet.
    
    D. International Residue Limits
    
        No CODEX, Canadian, or Mexican MRLs have been established for 
    residues of spinosad on any crops.
    
    IV. Conclusion
    
        Therefore, the tolerances are established for residues of spinosad 
    in almonds at 0.02 ppm; almond hulls at 2.0 ppm; apples at 0.2 ppm; 
    apple pomace, wet at 0.5 ppm; citrus fruits group at 0.3 ppm; citrus 
    pulp, dried at 0.5 ppm; citrus oil at 3.0 ppm; cottonseed at 0.02 ppm; 
    cotton gin byproducts at 1.5 ppm; fruiting vegetables (except 
    cucurbits) group at 0.4 ppm; Brassica (cole), leafy vegetables, head 
    and stem subgroup at 2.0 ppm; Brassica (cole), leafy vegetables, greens 
    subgroup at 10.0 ppm; leafy vegetables (except Brassica vegetables) 
    group at 8.0 ppm; fat of cattle, goats, hogs, horses, and sheep at 0.6 
    ppm; meat of cattle goats, hogs, horses, and sheep at 0.04; meat 
    byproducts of cattle, goats, hogs, horses, and sheep at 0.2 ppm; milk 
    fat at 0.5 ppm; and whole milk at 0.04 ppm.
    
    [[Page 18337]]
    
        In addition, EPA is removing the time limitation for the tolerance 
    for residues of spinosad on cottonseed. Also, EPA is removing the time 
    limited tolerances established under section 408(1)(6) of the FFDCA, as 
    amended by FQPA, in 40 CFR 180.495 (b) Section 18 emergency exemptions.
    
    V. Objections and Hearing Requests
    
        The new FFDCA section 408(g) provides essentially the same process 
    for persons to ``object'' to a tolerance regulation issued by EPA under 
    new section 408(e) and (l)(6) as was provided in the old section 408 
    and in section 409. However, the period for filing objections is 60 
    days, rather than 30 days. EPA currently has procedural regulations 
    which govern the submission of objections and hearing requests. These 
    regulations will require some modification to reflect the new law. 
    However, until those modifications can be made, EPA will continue to 
    use those procedural regulations with appropriate adjustments to 
    reflect the new law.
        Any person may, by June 15, 1998, file written objections to any 
    aspect of this regulation and may also request a hearing on those 
    objections. Objections and hearing requests must be filed with the 
    Hearing Clerk, at the address given above (40 CFR 178.20). A copy of 
    the objections and/or hearing requests filed with the Hearing Clerk 
    should be submitted to the OPP docket for this rulemaking. The 
    objections submitted must specify the provisions of the regulation 
    deemed objectionable and the grounds for the objections (40 CFR 
    178.25). Each objection must be accompanied by the fee prescribed by 40 
    CFR 180.33(i). If a hearing is requested, the objections must include a 
    statement of the factual issues on which a hearing is requested, the 
    requestor's contentions on such issues, and a summary of any evidence 
    relied upon by the requestor (40 CFR 178.27). A request for a hearing 
    will be granted if the Administrator determines that the material 
    submitted shows the following: There is genuine and substantial issue 
    of fact; there is a reasonable possibility that available evidence 
    identified by the requestor would, if established, resolve one or more 
    of such issues in favor of the requestor, taking into account 
    uncontested claims or facts to the contrary; and resolution of the 
    factual issues in the manner sought by the requestor would be adequate 
    to justify the action requested (40 CFR 178.32). Information submitted 
    in connection with an objection or hearing request may be claimed 
    confidential by marking any part or all of that information as CBI. 
    Information so marked will not be disclosed except in accordance with 
    procedures set forth in 40 CFR part 2. A copy of the information that 
    does not contain CBI must be submitted for inclusion in the public 
    record. Information not marked confidential may be disclosed publicly 
    by EPA without prior notice.
    
    VI. Public Docket
    
        EPA has established a record for this rulemaking under docket 
    control number [OPP-300644] (including any comments and data submitted 
    electronically). A public version of this record, including printed, 
    paper versions of electronic comments, which does not include any 
    information claimed as CBI, is available for inspection from 8:30 a.m. 
    to 4 p.m., Monday through Friday, excluding legal holidays. The public 
    record is located in Room 119 of the Public Information and Records 
    Integrity Branch, Information Resources and Services Division (7502C), 
    Office of Pesticide Programs, Environmental Protection Agency, Crystal 
    Mall #2, 1921 Jefferson Davis Highway, Arlington, VA.
        Electronic comments may be sent directly to EPA at:
        opp-docket@epamail.epa.gov.
    
    
        Electronic comments must be submitted as an ASCII file avoiding the 
    use of special characters and any form of encryption.
        The official record for this rulemaking, as well as the public 
    version, as described above will be kept in paper form. Accordingly, 
    EPA will transfer any copies of objections and hearing requests 
    received electronically into printed, paper form as they are received 
    and will place the paper copies in the official rulemaking record which 
    will also include all comments submitted directly in writing. The 
    official rulemaking record is the paper record maintained at the 
    Virginia address in ``ADDRESSES'' at the beginning of this document.
    
    VII. Regulatory Assessment Requirements
    
        This final rule establishes tolerances under FFDCA section 408(d) 
    in response to a petition submitted to the Agency. The Office of 
    Management and Budget (OMB) has exempted these types of actions from 
    review under Executive Order 12866, entitled Regulatory Planning and 
    Review (58 FR 51735, October 4, 1993). This final rule does not contain 
    any information collections subject to OMB approval under the Paperwork 
    Reduction Act (PRA), 44 U.S.C. 3501 et seq., or impose any enforceable 
    duty or contain any unfunded mandate as described under Title II of the 
    Unfunded Mandates Reform Act of 1995 (UMRA) (Pub. L. 104-4). Nor does 
    it require any prior consultation as specified by Executive Order 
    12875, entitled Enhancing the Intergovernmental Partnership (58 FR 
    58093, October 28, 1993), or special considerations as required by 
    Executive Order 12898, entitled Federal Actions to Address 
    Environmental Justice in Minority Populations and Low-Income 
    Populations (59 FR 7629, February 16, 1994), or require OMB review in 
    accordance with Executive Order 13045, entitled Protection of Children 
    from Environmental Health Risks and Safety Risks (62 FR 19885, April 
    23, 1997).
        In addition, since these tolerances and exemptions that are 
    established on the basis of a petition under FFDCA section 408(d), such 
    as the tolerances in this final rule, do not require the issuance of a 
    proposed rule, the requirements of the Regulatory Flexibility Act (RFA) 
    (5 U.S.C. 601 et seq.) do not apply. Nevertheless, the Agency has 
    previously assessed whether establishing tolerances, exemptions from 
    tolerances, raising tolerance levels or expanding exemptions might 
    adversely impact small entities and concluded, as a generic matter, 
    that there is no adverse economic impact. The factual basis for the 
    Agency's generic certification for tolerance actions published on May 
    4, 1981 (46 FR 24950) and was provided to the Chief Counsel for 
    Advocacy of the Small Business Administration.
    
    VIII. Submission to Congress and the Comptroller General
    
        The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the 
    Small Business Regulatory Envorcement Fairness Act of 1996, generally 
    provides that before a rule may take effect, the agency promulgating 
    the rule must submit a rule report, which includes a copy of the rule, 
    to each House of the Congress and to the Comptroller General of the 
    United States. EPA will submit a report containing this rule and other 
    required information to the U.S. Senate, the U.S. House of 
    Representatives, and the Comptroller General of the United States prior 
    to publication of the rule in the Federal Register. This rule is not a 
    ``major rule'' as defined by 5 U.S.C. 804(2).
    
    List of Subjects in 40 CFR Part 180
    
        Environmental protection, Administrative practice and procedure, 
    Agricultural commodities, Pesticides and pests, Reporting and 
    recordkeeping requirements.
    
    
    [[Page 18338]]
    
    
        Dated: April 9, 1998.
    
    James Jones,
    
    Director, Registration Division, Office of Pesticide Programs.
        Therefore, 40 CFR chapter I is amended as follows:
    
    PART 180--[AMENDED]
    
        1. The authority citation for part 180 continues to read as 
    follows:
    
        Authority : 21 U.S.C. 346a and 371.
    
        2. In Sec. 180.495, paragraphs (a) and (b) are revised to read as 
    follows:
    
    
    Sec. 180.495  Spinosad; tolerances for residues.
    
        (a) General. Tolerances are established for residues of the 
    insecticide Spinosad. Factor A is 2-[(6-deoxy-2,3,4-tri-O-methyl-
    -L-manno-pyranosyl)oxy]-13-[[5-(dimethylamino)-tetrahydro-6-
    methyl-2H-pyran-2-yl]oxy]-9-ethyl-
    2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,6b-tetradecahydro-14-methyl-1H-as-
    Indaceno[3,2-d]oxacyclododecin-7,15-dione. Factor D is 2-[(6-deoxy-
    2,3,4-tri-O-methyl--L-manno-pyranosyl)oxy]-13-[[5-
    (dimethylamino)-tetrahydri-6-methyl-2H-pyran-2-yl]oxy]-9-ethyl-
    2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-
    1H-as-Indaceno[3,2-d]oxacyclododecin-7,15-dione.
    
                                                                            
    ------------------------------------------------------------------------
                                                                  Parts per 
                             Commodity                             million  
    ------------------------------------------------------------------------
    Almonds....................................................         0.02
    Almond hulls...............................................          2.0
    Apples.....................................................          0.2
    Apple pomace, wet..........................................          0.5
    Brassica (cole), leafy vegetables, greens subgroup.........         10.0
    Brassica (cole), leafy vegetables, head and stem subgroup..          2.0
    Cattle, fat................................................          0.6
    Cattle, mbyp...............................................          0.2
    Cattle, meat...............................................         0.04
    Citrus fruits group........................................          0.3
    Citrus oil.................................................          3.0
    Citrus pulp, dried.........................................          0.5
    Cotton gin byproducts......................................          1.5
    Cottonseed.................................................         0.02
    Fruiting vegetables (except cucurbits) group...............          0.4
    Goat, fat..................................................          0.6
    Goat, mbyp.................................................          0.2
    Goat, meat.................................................         0.04
    Hogs, fat..................................................          0.6
    Hogs, mbyp.................................................          0.2
    Hogs, meat.................................................         0.04
    Horses, fat................................................          0.6
    Horses, mbyp...............................................          0.2
    Horses, meat...............................................         0.04
    Leafy vegetables (except Brassica vegetables) group........          8.0
    Milk, fat..................................................          0.5
    Milk, whole................................................         0.04
    Sheep, fat.................................................          0.6
    Sheep, mbyp................................................          0.2
    Sheep, meat................................................         0.04
    ------------------------------------------------------------------------
    
        (b) Section 18 emergency exemptions. [Reserved]
    * * * * *
    
    [FR Doc. 98-10023 Filed 4-14-98; 8:45 am]
    BILLING CODE 6560-50-F
    
    
    

Document Information

Effective Date:
4/15/1998
Published:
04/15/1998
Department:
Environmental Protection Agency
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-10023
Dates:
This regulation is effective April 15, 1998. Objections and requests for hearings must be received by EPA on or before June 15, 1998.
Pages:
18329-18338 (10 pages)
Docket Numbers:
OPP-300644, FRL-5785-7
RINs:
2070-AB78
PDF File:
98-10023.pdf
CFR: (1)
40 CFR 180.495